ADAM10 and T-cell acute lymphoblastic leukemia: Some researchers have suggested that inhibiting the ability of ADAM10 to mediate protein cleavage may reverse Notch1 signaling in T cell acute lymphoblastic leukemia, thereby suppressing tumorigenesis 29, 31.